Laurent Roussel

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

Johanne Silvain, Benoît Lattuca, Farzin Beygui et al. · The Lancet · 2020 · 122 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Disease +10

Comparison of two methods of i.v. insulin administration in the diabetic patient during the perioperative period

M. Raucoules‐Aimé, Carole Ichaï, Laurent Roussel et al. · British Journal of Anaesthesia · 1994 · 32 citations · Full text

Diabetes Management, Perioperative Period, Medicine +10

Effect of severity of surgery on metabolic control and insulin requirements in insulin-dependent diabetic patients

M. Raucoules‐Aimé, Laurent Roussel, D Rossi et al. · British Journal of Anaesthesia · 1995 · 15 citations · Full text

Obesity, Metabolic Syndrome, Bariatric Surgery +13

Prevalence, Management and Outcomes of Percutaneous Coronary Intervention for Coronary In-Stent Restenosis: Insights From the France PCI Registry

Benjamin Duband, Géraud Souteyrand, Jean Michel Clerc et al. · Cardiovascular revascularization medicine · 2023 · 13 citations · Full text